AssetMark Inc
ONC

AssetMark Inc’s BeOne Medicines Ltd ONC Stock Holding History

AssetMark Inc’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.23M Buy
32,399
+2,830
+10% +$834K 0.02% 579
2026
Q1 		$8.78M Buy
29,569
+4,755
+19% +$1.54M 0.02% 535
2025
Q4 		$7.54M Buy
24,814
+1,833
+8% +$600K 0.02% 559
2025
Q3 		$7.83M Buy
22,981
+1,834
+9% +$557K 0.02% 526
2025
Q2 		$5.12M Buy
21,147
+1,371
+7% +$336K 0.01% 575
2025
Q1 		$5.38M Buy
19,776
+1,235
+7% +$289K 0.01% 495
2024
Q4 		$3.42M Buy
18,541
+1,383
+8% +$283K 0.01% 589
2024
Q3 		$3.85M Sell
17,158
-1,450
-8% -$261K 0.01% 495
2024
Q2 		$2.65M Buy
18,608
+1,931
+12% +$298K 0.01% 544
2024
Q1 		$2.61M Buy
16,677
+4,781
+40% +$770K 0.01% 525
2023
Q4 		$2.15M Buy
11,896
+1,404
+13% +$254K 0.01% 522
2023
Q3 		$1.89M Buy
10,492
+961
+10% +$190K 0.01% 514
2023
Q2 		$1.7M Buy
9,531
+914
+11% +$210K 0.01% 508
2023
Q1 		$1.86M Buy
8,617
+2,768
+47% +$664K 0.01% 469
2022
Q4 		$1.29M Buy
5,849
+271
+5% +$49.7K 0.01% 521
2022
Q3 		$752K Buy
5,578
+960
+21% +$165K ﹤0.01% 581
2022
Q2 		$747K Buy
4,618
+732
+19% +$114K ﹤0.01% 567
2022
Q1 		$733K Buy
3,886
+2,238
+136% +$476K ﹤0.01% 545
2021
Q4 		$446K Buy
1,648
+1,360
+472% +$459K ﹤0.01% 561
2021
Q3 		$105K Buy
288
+58
+25% +$19K ﹤0.01% 640
2021
Q2 		$79K Buy
230
+1
+0.4% +$331 ﹤0.01% 676
2021
Q1 		$80K Buy
229
+35
+18% +$11.6K ﹤0.01% 656
2020
Q4 		$50K Buy
194
+11
+6% +$3.03K ﹤0.01% 713
2020
Q3 		$52K Buy
183
+27
+17% +$6.35K ﹤0.01% 669
2020
Q2 		$29K Buy
156
+2
+1% +$326 ﹤0.01% 746
2020
Q1 		$19K Buy
154
+3
+2% +$469 ﹤0.01% 887
2019
Q4 		$25K Sell
151
-7
-4% -$1.16K ﹤0.01% 890
2019
Q3 		$19K Hold
158
– – ﹤0.01% 894
2019
Q2 		$20K Buy
158
+1
+0.6% +$127 ﹤0.01% 885
2019
Q1 		$21K Buy
+157
New +$21.2K ﹤0.01% 877

Other funds holding ONC

AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AG
AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

AssetMark Inc's ONC Position: Q2 2026 in Review

AssetMark Inc increased its BeOne Medicines Ltd (ONC) stake by 9.6% in Q2 2026, buying an estimated $834K and bringing the position to 32,399 shares worth $9.23M. The position accounts for 0.02% of the portfolio, ranked #579.

AssetMark Inc first reported a position in ONC in Q1 2019 and has held it in 30 quarters since. 67 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • AssetMark Inc held 32,399 shares of BeOne Medicines Ltd worth $9.23M as of Q2 2026.
  • AssetMark Inc bought 2,830 BeOne Medicines Ltd shares in Q2 2026, an estimated $834K.
  • BeOne Medicines Ltd made up 0.02% of AssetMark Inc's portfolio in Q2 2026, its #579 holding.
  • AssetMark Inc first reported a position in BeOne Medicines Ltd in Q1 2019 and has held it in 30 quarters since.
  • 67 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.